Highlights CV Sciences, Inc.

Equities

CVSI

US1266541028

Market Closed - OTC Markets Other stock markets 15:58:24 2024-06-21 EDT			5-day change	1st Jan Change
0.0565 ^USD	+4.63%		-32.42%	+59.60%

06-07	CV Sciences, Inc. Elects Bill Mccorkle as Directors	CI
06-03	Transcript : CV Sciences, Inc. - Shareholder/Analyst Call

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CV Sciences Seeks M&A Opportunities	05-14	CI
CV Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
CV Sciences, Inc. acquired Elevated Softgels for $1.1 million.	05-12	CI
CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews	03-26	CI
CV Sciences, Inc. acquired Cultured Foods Sp. z.o.o for $0.535 million.	12-11	CI
CV Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
CV Sciences, Inc. Launches Reserve Sleep Gummies	23-09-05	CI
CV Sciences, Inc. Seeks Acquisitions	23-08-14	CI
CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
CV Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
CV Sciences Seeks M&A Opportunities	23-05-15	CI
Earnings Flash (CVSI) CV SCIENCES Posts Q1 EPS $0.04	23-05-15	MT
CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
CV Sciences, Inc. Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol and Nicotine for Treating Smokeless Tobacco Addiction	23-03-23	CI
CV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgels	23-03-21	CI
CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD Reserve Collection Softgels	23-01-18	CI
Earnings Flash (CVSI) CV SCIENCES Posts Q3 Loss $-0.01	22-11-14	MT
CV Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
CV Sciences, Inc. Announces Launch of PlusCBD Reserve Collection Softgels	22-08-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights CV Sciences, Inc.

Equities

CVSI

US1266541028

Highlights

Filters